These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 28464333)
21. Mutant prevention concentration, pharmacokinetic-pharmacodynamic integration, and modeling of enrofloxacin data established in diseased buffalo calves. Ramalingam B; Sidhu PK; Kaur G; Venkatachalam D; Rampal S J Vet Pharmacol Ther; 2015 Dec; 38(6):529-36. PubMed ID: 25776301 [TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetic/pharmacodynamic relationship of enrofloxacin against Aeromonas hydrophila in crucian carp (Carassius auratus gibelio). Shan Q; Wang J; Wang J; Ma L; Yang F; Yin Y; Huang R; Liu S; Li L; Zheng G J Vet Pharmacol Ther; 2018 Dec; 41(6):887-893. PubMed ID: 29943470 [TBL] [Abstract][Full Text] [Related]
23. In Vitro Anaerobic Pharmacokinetic/Pharmacodynamic Model to Simulate the Bactericidal Activity of Levornidazole Against Bacteroides fragilis. Hu J; Zhang J; Chen Y; Liang W; Wu S Clin Ther; 2017 Apr; 39(4):828-836. PubMed ID: 28363695 [TBL] [Abstract][Full Text] [Related]
24. The occurrence of antibiotic resistance in Clostridium perfringens from pigs. Rood JI; Buddle JR; Wales AJ; Sidhu R Aust Vet J; 1985 Aug; 62(8):276-9. PubMed ID: 2865949 [TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetic and pharmacodynamic testing of marbofloxacin administered as a single injection for the treatment of bovine respiratory disease. Vallé M; Schneider M; Galland D; Giboin H; Woehrlé F J Vet Pharmacol Ther; 2012 Dec; 35(6):519-28. PubMed ID: 22126438 [TBL] [Abstract][Full Text] [Related]
26. Integration of pharmacokinetic and pharmacodynamic indices of marbofloxacin in turkeys. Haritova AM; Rusenova NV; Parvanov PR; Lashev LD; Fink-Gremmels J Antimicrob Agents Chemother; 2006 Nov; 50(11):3779-85. PubMed ID: 16940071 [TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetic and Pharmacodynamic Integration and Modeling of Enrofloxacin in Swine for Escherichia coli. Wang J; Hao H; Huang L; Liu Z; Chen D; Yuan Z Front Microbiol; 2016; 7():36. PubMed ID: 26870006 [TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetic/pharmacodynamic relationship of marbofloxacin against Aeromonas hydrophila in Chinese soft-shelled turtles (Trionyx sinensis). Shan Q; Zheng G; Liu S; Bai Y; Li L; Yin Y; Ma L; Zhu X J Vet Pharmacol Ther; 2015 Dec; 38(6):537-42. PubMed ID: 25694049 [TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetic and Pharmacodynamic Evaluation of Marbofloxacin and PK/PD Modeling against Lei Z; Liu Q; Xiong J; Yang B; Yang S; Zhu Q; Li K; Zhang S; Cao J; He Q Front Pharmacol; 2017; 8():542. PubMed ID: 28871226 [TBL] [Abstract][Full Text] [Related]
30. Mutant prevention concentration and PK-PD relationships of enrofloxacin for Pasteurella multocida in buffalo calves. Balaje RM; Sidhu PK; Kaur G; Rampal S Res Vet Sci; 2013 Dec; 95(3):1114-24. PubMed ID: 23941961 [TBL] [Abstract][Full Text] [Related]
31. PK/PD modeling of Ceftiofur Sodium against Haemophilus parasuis infection in pigs. Li XD; Chi SQ; Wu LY; Liu C; Sun T; Hong J; Chen X; Chen XG; Wang GS; Yu DJ BMC Vet Res; 2019 Aug; 15(1):272. PubMed ID: 31370843 [TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetic/pharmacodynamic integration of cefquinome against Pasteurella Multocida in a piglet tissue cage model. Zhang L; Wu X; Huang Z; Kang Z; Chen Y; Shen X; Cai Q; Ding H J Vet Pharmacol Ther; 2019 Jan; 42(1):60-66. PubMed ID: 30407642 [TBL] [Abstract][Full Text] [Related]
33. In vitro Dynamic Pharmacokinetic/Pharmacodynamic (PK/PD) study and COPD of Marbofloxacin against Haemophilus parasuis. Sun J; Xiao X; Huang RJ; Yang T; Chen Y; Fang X; Huang T; Zhou YF; Liu YH BMC Vet Res; 2015 Dec; 11():293. PubMed ID: 26626889 [TBL] [Abstract][Full Text] [Related]
34. Prediction of marbofloxacin dosage for the pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida by pharmacokinetic/pharmacodynamic modelling. Dorey L; Pelligand L; Lees P BMC Vet Res; 2017 Jul; 13(1):209. PubMed ID: 28666426 [TBL] [Abstract][Full Text] [Related]
35. Incidence and Antimicrobial Susceptibility to Clostridium perfringens in Premarket Broilers in Taiwan. Fan YC; Wang CL; Wang C; Chen TC; Chou CH; Tsai HJ Avian Dis; 2016 Jun; 60(2):444-9. PubMed ID: 27309285 [TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics, Pharmacodynamic Efficacy Prediction Indexes and Monte Carlo Simulations of Enrofloxacin Hydrochloride Against Bacterial Strains That Induce Common Clinical Diseases in Broiler Chickens. Bonassa KPD; Miragliotta MY; Simas RC; Eberlin MN; Anadón A; Moreno RA; Reyes FGR Front Vet Sci; 2020; 7():606872. PubMed ID: 33490134 [TBL] [Abstract][Full Text] [Related]
37. Epidemiological and PK/PD cutoff values determination and PK/PD-based dose assessment of gamithromycin against Haemophilus parasuis in piglets. Zhou YF; Bu MX; Liu P; Sun J; Liu YH; Liao XP BMC Vet Res; 2020 Mar; 16(1):81. PubMed ID: 32138735 [TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetic and pharmacodynamic modeling of sarafloxacin against avian pathogenic Escherichia coli in Muscovy ducks. Yu Y; Zhou YF; Sun J; Shi W; Liao XP; Liu YH BMC Vet Res; 2017 Feb; 13(1):47. PubMed ID: 28183350 [TBL] [Abstract][Full Text] [Related]
39. Simultaneous determination of multicomponent of acetylkitasamycin and kitasamycin by LC-MS/MS in swine plasma and its application in a pharmacokinetic study. Pan Y; Zhang H; Xi C; Huang L; Xie S; Chen D; Tao Y; Liu Z; Yuan Z Biomed Chromatogr; 2018 May; ():e4268. PubMed ID: 29722050 [TBL] [Abstract][Full Text] [Related]
40. Genotyping and antimicrobial susceptibility of Clostridium perfringens isolated from dromedary camels, pastures and herders. Fayez M; Elsohaby I; Al-Marri T; Zidan K; Aldoweriej A; El-Sergany E; Elmoslemany A Comp Immunol Microbiol Infect Dis; 2020 Jun; 70():101460. PubMed ID: 32145560 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]